Cargando…
不同剂量紫杉醇联合卡铂一线治疗晚期非小细胞肺癌的临床研究
BACKGROUND AND OBJECTIVE: The combination of pacilitaxel and carboplatin has become a widely used regimen in frst-line therapy of advanced NSCLC. The aim of this study is to compare the efcacy and safety of paclitaxel plus carboplatin at two dose levels in the frst-line treatment of advanced NSCLC p...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999718/ https://www.ncbi.nlm.nih.gov/pubmed/21496430 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.04.04 |
Ejemplares similares
-
贝伐珠单抗联合紫杉醇/卡铂治疗晚期非小细胞肺癌25例分析
Publicado: (2012) -
紫杉醇脂质体联合顺铂方案一线治疗晚期非小细胞肺癌的临床随机对照研究
Publicado: (2012) -
艾迪联合紫杉醇和顺铂治疗晚期非小细胞肺癌的meta分析
Publicado: (2010) -
紫杉醇脂质体单药与紫杉醇脂质体联合奥沙利铂一线治疗老年晚期非小细胞肺癌的随机对照研究
Publicado: (2012) -
紫杉醇联合卡铂三周方案同步胸部放疗治疗不宜手术的局部晚期非小细胞肺癌疗效和安全性研究:一项来自单中心的回顾性研究
Publicado: (2016)